Next Article in Journal
Inactivation of Bacteria and Residual Antimicrobials in Hospital Wastewater by Ozone Treatment
Next Article in Special Issue
Genomic Characterization of International High-Risk Clone ST410 Escherichia coli Co-Harboring ESBL-Encoding Genes and blaNDM-5 on IncFIA/IncFIB/IncFII/IncQ1 Multireplicon Plasmid and Carrying a Chromosome-Borne blaCMY-2 from Egypt
Previous Article in Journal
Editorial for Special Issue “Alternatives to Antibiotics: Bacteriocins and Antimicrobial Peptides”
Previous Article in Special Issue
Comparative Genomics of 42 Arcanobacterium phocae Strains
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antibiotics
Volume 11
Issue 7
10.3390/antibiotics11070861
antibiotics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Whole-Genome Sequence of Multidrug-Resistant Methicillin-Resistant Staphylococcus epidermidis Carrying Biofilm-Associated Genes and a Unique Composite of SCCmec

by
Hisham N. Altayb
1,2,*,
Hana S. Elbadawi
3,
Othman Baothman
1,
Imran Kazmi
1,
Faisal A. Alzahrani
1,
Muhammad Shahid Nadeem
1,
Salman Hosawi
1,2 and
Kamel Chaieb
1,4
1
Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2
Centre for Artificial Intelligence in Precision Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia
3
Microbiology and Parasitology Department, Soba University Hospital, University of Khartoum, Khartoum 11115, Sudan
4
Laboratory of Analysis, Treatment and Valorization of Pollutants of the Environmental and Products, Faculty of Pharmacy, University of Monastir, Monastir 5000, Tunisia
*
Author to whom correspondence should be addressed.
Antibiotics 2022, 11(7), 861; https://doi.org/10.3390/antibiotics11070861
Submission received: 16 May 2022 / Revised: 20 June 2022 / Accepted: 22 June 2022 / Published: 24 June 2022
(This article belongs to the Special Issue Antimicrobial Resistance: What Can We Learn from Genomics?)
Browse Figures
Versions Notes

Abstract

:
Staphylococcus epidermidis is part of the normal human flora that has recently become an important opportunistic pathogen causing nosocomial infections and tends to be multidrug-resistant. In this investigation, we aimed to study the genomic characteristics of methicillin-resistant S. epidermidis isolated from clinical specimens. Three isolates were identified using biochemical tests and evaluated for drug susceptibility. Genomic DNA sequences were obtained using Illumina, and were processed for analysis using various bioinformatics tools. The isolates showed multidrug resistance to most of the antibiotics tested in this study, and were identified with three types (III(3A), IV(2B&5), and VI(4B)) of the mobile genetic element SCCmec that carries the methicillin resistance gene (mecA) and its regulators (mecI and mecR1). A total of 11 antimicrobial resistance genes (ARGs) was identified as chromosomally mediated or in plasmids; these genes encode for proteins causing decreased susceptibility to methicillin (mecA), penicillin (blaZ), fusidic acid (fusB), fosfomycin (fosB), tetracycline (tet(K)), aminoglycosides (aadD, aac(6′)-aph(2′’)), fluoroquinolone (MFS antibiotic efflux pump), trimethoprim (dfrG), macrolide (msr(A)), and chlorhexidine (qacA)). Additionally, the 9SE strain belongs to the globally disseminated ST2, and harbors biofilm-formation genes (icaA, icaB, icaC, icaD, and IS256) with phenotypic biofilm production capability. It also harbors the fusidic acid resistance gene (fusB), which could increase the risk of device-associated healthcare infections, and 9SE has been identified as having a unique extra SCC gene (ccrB4); this new composite element of the ccr type needs more focus to better understand its role in the drug resistance mechanism.

1. Introduction

In the past decades, antibiotics have played a crucial role in fighting microbial infections. However, the overuse of antibiotics in clinical practice poses a serious risk to the public, and contributes to the emergence of multidrug-resistant (MDR) Staphylococcus aureus, which is responsible for various persistent and chronic infections [1]. Methicillin-resistant S. epidermidis (MRSE) is classified as a pathogen related to nosocomial and community-acquired infections [2]. S. epidermidis can become methicillin-resistant via the acquisition of the mecA gene, which is transferred with the help of staphylococcal chromosomal cassette mec (SCCmec) [3]. The failure of antibiotic therapy may be linked to the accumulation of resistance-relevant genes, as well as the flexibility changes in bacterial phenotypes [4]. MDR staphylococci can survive in hostile environments by forming biofilms or switching into small colony variants (SCVs) [1]. The genetic plasticity of Staphylococcal species has aided in the emergence of several drug-resistant strains, posing a significant therapeutic problem [5]. High prevalence of MRSE has been documented among clinical isolates in countries such as Iran (73.9 95%) [6], India (68%) [6], and Spain (37.2%) [7].
Coagulase-negative staphylococci (CoNS) are one of the most important human skin microbiota [8]. CoNS are also thought to be a significant reservoir of resistance genes. Recently, researchers have revealed that CoNS isolated from clinical samples and healthcare workers’ skin have a high rate of drug resistance and a variety of SCCmec types [9]. According to Bekoe et al. [10], tetracycline (63%) and ciprofloxacin (54%) were the drugs with the highest resistance identified in CoNS isolated from 401 urine samples of healthy individuals from Ghana. Due to the increase in drug resistance and invasive surgical procedures, CoNS are a global public health problem [11]. Even though CoNS are normally thought to be harmless, they are commonly linked to nosocomial illnesses, sparking increased interest in them as pathogens rather than as contaminants. The most common infections caused by CoNS are urinary tract infections (UTIs), eye infections, surgical site infections, and prosthetic joint infections [12]. S. epidermidis is the most common bacterium that is responsible for a significant number of nosocomial infections associated with medical implants (e.g., prosthetic devices and catheters), due to its ability to form a biofilm, which aids in attachment to inert biomaterial surfaces and increases antibiotic tolerance [12]. S. epidermidis infections are frequently chronic, with few distinguishing symptoms, so its distinct identification from other Staphylococci is necessary for accurate diagnosis [13]. In recent years, CoNS have attracted a lot of attention as pathogenic causes of infections in humans—particularly in immunocompromised, critically ill, or long-term hospitalized patients, and those with invasive medical devices, such as catheters. They have been connected to infections such as urinary tract infections, bloodstream infections, and infections caused by intrusive devices [14]. While distinguishing between harmless and pathogenic CoNS remains challenging, breakthroughs in diagnostic methods have increased our understanding of pathogenicity’s molecular mechanisms.
The staphylococcal cassette chromosome (SCC) is considered to be one of the most important mobile genetic elements in staphylococcal species, responsible for the mobility of methicillin resistance genes among different staphylococcal species [15]. To date, 14 variants of SCCmec types have been identified around the world, and these elements have been used in staphylococci evolution research, in addition to being used as molecular epidemiology tools in healthcare settings [16]. Among MRSE species, the IV(2B&5) SCCmec was reported as the most dominant SCCmec element type, and the SCCmec type III(3A) has been previously documented predominantly in healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) infections [17]. Although S. epidermidis is becoming an important opportunistic pathogen causing nosocomial infections, and tends to be more multidrug-resistant [18], it is often wrongly identified as a contaminant, despite causing many serious infections [14]. This study aimed to investigate and characterize the SCCmec elements, virulence factors, and ARGs in methicillin-resistant S. epidermidis strains isolated from clinical specimens.

2. Results

2.1. Isolation and Susceptibility Testing of S. epidermidis

The isolates were obtained from patients attending Soba University Hospital in Khartoum State suffering from chronic urinary tract infections (9SE) and chronic skin infections (14SP), and 5-day-old neonates suffering from sepsis (30SP) (Supplementary File S1, Table S1). The isolates were multidrug-resistant, and exhibited different levels of resistance to ciprofloxacin, tetracycline, cefoxitin, erythromycin, clindamycin, trimethoprim–sulfamethoxazole, gentamicin, chloramphenicol, and ampicillin. The isolates were resistant to cefoxitin, and they showed high levels of resistance to chloramphenicol and ampicillin. The isolates’ MIC values for chloramphenicol were reported to be ≥256 µgm/L, while the chloramphenicol (30 µg/L) disk diffusion susceptibility test showed no zone of inhibition with isolates 9SE and 30SP. A high level of resistance to ampicillin was observed in isolates 9SE and 14SP, in which the MIC reached 256 and 1024 µgm/L, respectively. Meanwhile, isolates 14SP and 30SP exhibited a small zone of inhibition (≤12), and an MIC value of 256 µg/L was recorded (Table 1).

2.2. Phenotypic Detection of Biofilm

By using the semi-quantitative microtiter plate method for estimation of the slime production, isolates 14SP and 30SP showed very weak positive results, with optical densities of 0.119 ± 0.04 and 0.116 ± 0.02, respectively. The isolate 9SE showed a weak positive result, with an OD of 0.318 ± 0.05. When using Congo red agar, isolates 14SP and 30SP produced dark pink colonies that were considered moderate slime producers, while isolate 9SE produced dark black colonies, which were considered positive (Supplementary File S1, Figure S1).

2.3. Characterization and Typing of Bacterial Genomes

The isolates (9SE, 14SP, and 30SP) were assembled in 2.5, 2.52, and 2.46 Mb, respectively; the number of contigs was ≤45, and the coverage was ≥370. The assembled genomes were identified at the species level using the PubMLST database, in which the isolates showed 100% identity with S. epidermidis. The isolates 9SE and 30SP were identified with sequence types (STs) 2 and 369, respectively, while the isolate 14SP was identified with novel alleles, and was assigned with a novel ID (736) by the Institut Pasteur team for the curation and maintenance of BIGSdb-Pasteur databases.
Comparing the genomics of our isolates to different strains of S. epidermidis (i.e., 949_S8, BPH0662, RP62A, and ATCC_12228) revealed that the species formed 3092 gene clusters, 2936 orthologous clusters, and 156 single-copy gene clusters. The isolates (9SE, 14SP, and 30SP) formed 96, 99, and 73 singleton proteins, respectively (Table 2) (Supplementary File S1, Figure S2). Comparison of the isolates’ whole genomic data with the BIGSdb-Pasteur database loci revealed the presence of the multidrug efflux pump (QacA) gene, which causes resistance to chlorhexidine, in isolate 9SE, while isolates 14SP and 30SP lacked this gene. The phenol-soluble modulins’ virulence factors (PSM-b1 and PSM-mec), genes associated with biofilm formation (icaA, icaB, icaC, and icaD), and their regulator (icaR) were present in the 9SE isolate, while the formate dehydrogenase (fdh) gene was detected only in the 14SP and 30SP isolates (Table 3). The 9SE isolate was identified with a cluster of phage proteins, Staphylococcal nuclease family proteins, mobile element proteins, transposases, and mecA adaptor proteins (Supplementary File S1, Figure S3).

2.4. Staphylococcal Cassette Chromosome (SCC) Detection and Typing

We used SCCmecFinder v1.2 to understand the diversity of mecA-encoding genes. According to the nomenclature used for MRSA, we identified a cassette of ccrB3, ccrA3, mecA, mecR1, and mecI genes corresponding to SCCmec type III(3A) in isolate 9SE, in which high nucleotide sequence identity (100%) was observed with S. aureus SCCmec type III(3A) (AB037671.1), and the psm-mec gene was found to be integrated into the SCCmec type III(3A) (Figure 1A). Additionally, 9SE contained another SCC cassette composed only of ccrC2 and IS257 transposases (Figure 2). The 9SE ccrA4 exhibited a high nucleotide similarity (99.85%) to ccrA4 of S. aureus strain HDE288, while ccrB4 exhibited a 94% nucleotide similarity to the S. aureus strain BK20781 ccrB4 gene (Table 4).
Isolate 14SP contains a type IV(2B&5) SCCmec cassette that contains mecA, dmecR1, IS1272, ccrB2, ccrC1 and ccrA2. The ccrB4 gene exhibited 100% identity to S. aureus strain CHE482′s cassette chromosome recombinase A (ccrA4-2) (EF126186.1) (Figure 1B). Prediction of the SCCmec cassette of the 30SP strain revealed the presence of SCCmec type VI(4B), which showed 87.47% coverage of the S. aureus strain HDE288 type VI SCCmec element, with a cassette consisting of the type B1 mec complex (IS257-mecA-mecR-IS1272) and the ccrA/B (type IV) (Figure 1C).

2.5. Antimicrobial Resistance Genes, Mobile Genetic Elements, and Virulence Factors

We investigated the genomic data of S. epidermidis for the presence of specific genetic features associated with bacterial pathogenicity and drug resistance. A total of 11 ARGs was identified as chromosomally mediated or present in plasmids; these genes encode for proteins causing decreased susceptibility to methicillin (mecA), penicillin (blaZ), fusidic acid (fusB), fosfomycin (fosB), tetracycline (tet(K)), aminoglycosides (aadD, aac(6′)-aph(2″)), fluoroquinolone (MFS antibiotic efflux pump), trimethoprim (dfrG), macrolide (msr(A)), and chlorhexidine (qacA) (Table 5). Isolate 9SE was identified as having seven ARGs (i.e., fosB, fusB, mecA, aac(6′)-aph(2″), fosD, qacA, and mupA). Genes encoding for fosfomycin (fosB), antiseptic resistance protein (qacA), and type II restriction enzymes (DpnII) were identified as being clustered in the 9SE plasmid, flanked by replication initiation protein A (repA) (Supplementary File S1, Figure S4). Isolate 14SP harbored different ARGs (i.e., aadD, msr(A), fosB, blaZ, dfrG, fusB, mecA, and aac(6′)-aph(2″)) and/or a point mutation (T173A) in S. aureus gyrB, conferring resistance to aminocoumarin.
As shown in Table 5, different ARGs causing resistance to various antibiotics used for the treatment of staphylococcal infections were noted in the 30SP strain. Class A beta-lactamase gene (blaZ), macrolide resistance gene (msr(A), phage protein, and replication initiation protein A (repA) were identified as being clustered in the plasmid (pSER10C-2) of 30SP (Supplementary File S1, Figure S5). The (MFS) antibiotic efflux pump (tet(K)) was identified in the 30SP isolate, with 100% identity and coverage; this gene was detected to be flanked by replication initiation protein (repA) and topoisomerase. Moreover, the MFS antibiotic efflux pump gene (norA) was identified in 9SE, 14SP, and 30SP, with identity of 100%, 98.7%, and 99.5%, respectively.
Genes responsible for adherence—including autolysin (atl), cell-wall-associated fibronectin-binding protein (ebh), elastin-binding protein (ebp), and Ser–Asp-rich fibrinogen-binding proteins (sdrG)—were identified in the three isolates (9SE, 14SP, and 30SP) and the control (RP62A). Similarly, the cysteine protease (sspB), lipases (geh and lip), serine V8 protease (sspA), thermonuclease (nuc), and beta-hemolysin (hlb) genes were detected in all four isolates, including the reference, while intercellular adhesin genes (i.e., icaA, icaB, icaC, icaD, and icaR) and Ser–Asp-rich fibrinogen-binding proteins (sdrF) were documented only in the 9SE strain (Supplementary File S1, Table S2).

2.6. Phylogenetic Analysis

In order to see the relationships between S. epidermidis strains, SNP-based phylogenetic analysis was performed after the alignment of the core genome. Isolate 14SP was located in a separate clade, while the 9SE and 30SP isolates were clustered in a clade containing S. epidermidis strains from different African countries—including Nigeria (1441, 1437, and 1443) and Ghana (1584 and 1582)—that were isolated from patients with bacteremia (Figure 3); the metadata of the reference strains used for comparison can be found in Supplementary File S2.

3. Discussion

S. epidermidis is part of the normal human flora, predominantly colonizing the adult skin [20], and on many occasions it is wrongly identified as a contaminant, despite causing many serious infections [14]. In recent years, it has become an important opportunistic pathogen causing nosocomial infections, and it tends to be multidrug-resistant [18]. In this study, three clinical isolates of S. epidermidis were identified as multidrug-resistant, showing resistance to various antibiotics, including cefoxitin. The staphylococcal cassette chromosome (SCC) is considered to be one of the most important mobile genetic elements in staphylococci, being responsible for the mobility of methicillin resistance genes among different staphylococcal species [15]. Since the first reports of SCCmec I, II, and III in the early 2000s, up to 14 variants of SCCmec elements have been reported by various researchers around the world, and these elements have been used for the study of staphylococci’s evolution, and also used as molecular epidemiology tools in healthcare settings [16]. These investigations have also raised concerns about the presence of SCCmec in clinical isolates being misinterpreted. In this study, for the first time in Sudan, we reported the presence of the SCCmec type among MRSE; a cassette of ccrB3, ccrA3, mecA, mecR1, and mecI genes corresponding to SCCmec type III(3A) was identified in isolate 9SE, with high nucleotide sequence identity (100%) with S. aureus SCCmec type III(3A) (AB037671.1). The SCCmec type III(3A) has been previously documented predominantly in healthcare-associated MRSA infections [17], which could indicate the possible horizontal transmission of this cassette from S. aureus to S. epidermidis species. The IV(2B&5) SCCmec was reported as the most dominant SCCmec element among methicillin-resistant S. epidermidis (MRSE) [17]; here, it was documented in isolate 14SP, which contains the mecA, dmecR1, IS1272, ccrB2, ccrC1, and ccrA2 genes. As reported in this study, the combination of ccr1, ccr2, and ccrC is usually detected in the IV(2B&5) SCCmec type [17]. In addition to the presence of the ccrA/B element in isolate 9SE, an extra ccrB4 was uniquely identified in this study; this new composite element of ccr elements needs more focus to better understand its role in the drug resistance mechanism. The existence of SCCmec type VI(4B) was discovered in the 30SP strain, which demonstrated 87.47% identity with the S. aureus strain HDE288 type-VI SCCmec element. The cassette consists of the type B1 mec complex (IS257-mecA-mecR-IS1272) and ccrAB (type 4) genes. This is consistent with a previous study in which the authors reported the presence of SCCmec type VI(4B) in MRSE [21].
Bacterial virulence is a complex topic that requires research from a clinical, molecular, and genetic perspective. In clinical terminology, virulence refers to a pathogen’s inherent ability to induce specific clinical symptoms that are thought to be linked to the production of different virulence factors [11]. The virulence and pathogenicity of three clinical S. epidermidis strains were investigated in this study. Even though strains belonging to the clonal type ST2 have been over-represented—especially in S. epidermidis newborn sepsis—none of the virulence factors could be used as a reliable factor for identification of a specific strain as harmful or commensal.
The insertion sequence IS256 and the ica genes are usually found in ST2 clonal types, which have been linked to biofilm generation and hospital-acquired infection [22]. This is consistent with our study, in which the ST2 strain was found in a hospitalized patient suffering from a chronic urinary tract infection. Multiple virulence factors have been discovered in the S. aureus genome, according to numerous studies; S. epidermidis carried nearly half of those factors [23]. The 9SE MRSE-ST2 strain was reported with the fusidic acid resistance gene (fusB); the clinical clones of MRSE-ST2 became globally epidemic, resulting in outbreaks [24]; and the fusidic acid MRSE-ST2 was the most common ST among clinical isolates in the USA, German, China, and others [25,26,27]. The circulation of such strains in hospitals was reported in South Africa, as shown in phylogenetic tree strains 1033, 1035, 1036, and 1037, which belonged to ST2, and were isolated from the blood of hospitalized patients in Pretoria. This was consistent with our findings, where 9SE was recovered from a hospitalized patient suffering from chronic UTI, indicating that the MRSE-ST2 clone has disseminated in our region.
Prophages, insertion sequences, and SCCmec-like cassettes were among the mobile genetic elements discovered in S. epidermidis genomes. Other possible virulence factors include proteases (serine and cysteine proteases), lipases, and hemolysin (e.g., beta/delta hemolysin) loci. The existence of mobile genetic elements and virulence factors could promote horizontal gene transfer between staphylococci and increase their pathogenicity [22]. The present study noted that seven ARGs (i.e., fosB, fusB, mecA, aac(6′)-aph(2″), fosD, qacA, and mupA) were present in isolate 9SE. Different ARGs (aadD, msr(A), fosB, blaZ, dfrG, fusB, mecA, and aac(6′)-aph(2″) were found in isolate 14SP, as well as a point mutation (T173A) in the gyrB gene that causes resistance to aminocoumarin. Moreover, the multidrug efflux pump (QacA) gene was observed in isolate 9SE, causing resistance to chlorhexidine, which is used for skin disinfection before surgeries [28]. In the hospital setting, chlorhexidine is the most frequently used antiseptic [29]; the presence of isolates resistant to chlorhexidine and the most commonly used antibiotics represents a serious public health problem. The presence of these ARGs was inconsistent with phenotypic antimicrobial resistance findings. We noted that all of the isolates showed varying levels of resistance to ampicillin, which could be attributed to the presence of the class A beta-lactamase (blaZ) gene and methicillin resistance mechanism [30]. The high level of resistance to methicillin could be attributed to widely prescribed β-lactam antibiotics for the treatment of different bacterial infections in Sudan [31], which are commonly used for prophylaxis before surgeries [28]. In the 30SP strain, we detected different ARGs that may induce resistance to conventional drugs used to treat staphylococcal infections. The presence of these genes is reflected in phenotypic resistance to ciprofloxacin, tetracycline, cefoxitin, trimethoprim–sulfamethoxazole, gentamicin, and ampicillin. The plasmid (pSER10C-2) of 30SP contained the genes related to resistance for class A beta-lactamase (blaZ), macrolide resistance (msr(A)) gene, phage protein, and replication initiation protein A (repA). Phage protein and replication initiation protein A (repA) are frequently found in multidrug-resistant plasmids [32]. Researchers have noted that most staphylococcal multidrug-resistant plasmids possess a highly conserved repA protein [33]. The major facilitator superfamily (MFS) antibiotic efflux pump (tet(K)) gene was found to be flanked by replication initiation protein and topoisomerase in the 30SP isolate. This could be the reason behind the high resistance rate against tetracycline observed in the 30SP isolate. Despite the absence of the chloramphenicol resistance gene (cat) in our isolates, they exhibited a high level of resistance (MIC ≥ 256) to chloramphenicol, which could be attributed to the presence of other resistance mechanisms such as multidrug efflux pumps in our isolates [34]. A high level of resistance (MIC = 256) was observed in isolates 14SP and 30SP, which could be attributed to the presence of the MFS antibiotic efflux pump, which is associated with the fluoroquinolone resistance mechanism [35].
S. epidermidis has an open-pan genome that includes core genes (80%) and variable genes (20%) [36]. The pan-genome analysis of the isolates revealed the presence of phenol-soluble modulin (PSM) genes in isolate 9SE; the PSM genes have recently been identified as significant virulence factors, most notably in aggressive strains of S. aureus [37]. The presence of the IS256 and ica genes was used as a measure of the pathogenicity of S. epidermidis [38]. The 9SE strain possessed genes associated with biofilm formation (icaA, icaB, icaC, and icaD), IS256, and the gene regulator (icaR); biofilm-forming isolates have more capacity to adhere to medical devices, thus increasing the risk of device-associated infections [20]. Isolates harboring the biofilm-associated genes, the antiseptic resistance gene qacA, the cassette genes (ccrA and ccrB), and the IS256-like transposase gene were more likely to be found in patients who had several procedures as a consequence of therapeutic failure [39]. Although strains 14SP and 30SP lack the IS256 and ica genes, they were positive for other adhesins such as autolysin (atl), cell-wall-associated fibronectin-binding protein (ebh), elastin-binding protein (ebp), and Ser–Asp-rich fibrinogen-binding proteins (sdrG). Similarly, they were positive for other virulence factors, including cysteine protease (sspB), lipases (geh and lip), serine V8 protease (sspA), thermonuclease (nuc), and beta-hemolysin (hlb), which could increase their pathogenicity and differentiate them from the commensal strains [38].
Phenotypic detection of biofilm formation showed that all of the isolates are weak biofilm producers; isolate 9SE had higher OD values than 14SP and 30SP, which could be attributed to the presence of ica genes. Although isolates 14SP and 30SP are ica-gene-negative isolates they showed weak phenotypic biofilm production, which could be attributed to the presence of ica-independent mechanisms of biofilm production [40].

4. Methods

4.1. Bacterial Isolates

Three isolates of coagulase-negative staphylococci (CoNS) species were identified as a part of a study conducted in Soba University Hospital to investigate the presence of drug-resistant bacteria in clinical settings during the period between November and May of 2021.
The clinical samples were processed as a part of the daily routine of clinical sample identification and processing at Soba University Hospital. The isolates were obtained from different patients suffering from chronic urinary tract infections (9SE) and chronic skin infections (14SP), as well as 5-day-old neonates suffering from sepsis (30SP) (Supplementary File S1, Table S1), and were selected based on their resistance to cefoxitin. The clinical isolates were identified by standard biochemical tests [41], and according to their colors and growth characteristics on chromogenic media.

4.2. Antimicrobial Susceptibility Testing

The isolates were subjected to disk diffusion antimicrobial susceptibility testing using the following antibiotics: ciprofloxacin (5 µg), tetracycline (30 µg), cefoxitin (30 µg), gentamicin (10 µg) erythromycin (15 µg), clindamycin (2 µg), trimethoprim–sulfamethoxazole (25 µg), and chloramphenicol (30 µg). The minimum inhibitory concentrations (MICs) of ciprofloxacin, tetracycline, gentamicin, chloramphenicol, and ampicillin were determined using the microtiter broth dilution method [42]. Overnight bacterial growth was adjusted to 5-105 CFU/mL in Mueller–Hinton (MH) broth and then used for the preparation of twofold serial dilution of antibiotics; then, 100 μL of broth was poured into each well. The antibiotic concentrations used were in the range of 2 to 1024 μg/mL [43]. MIC results were interpreted according to the CLSI guidelines [19].
The American Type Culture Collection (ATCC) S. aureus (ATCC 25923) strain was used for quality control of media and antibiotic disks. Results were interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [19].

4.3. Phenotypic Detection of Biofilm Production

Phenotypic biofilm assay was conducted using two methods: the microtiter plate (MtP) and Congo red agar (CRA) methods, as described by Chaieb et al. [44]. In the MtP method, the isolates were cultured overnight at 37 °C in brain–heart infusion broth (BHI, HiMedia, Mumbai, India) with 2% (w/v) glucose, and then the culture was diluted to 1: 100, and a total of 200 µL of diluted cultures was transferred to a 96-well polystyrene microplate (Nunc, Denmark), where each sample was tested in quintuplicate, including the positive control (S. epidermidis, CIP106510). After overnight incubation at 37 °C, the wells were washed, air-dried, fixed with 95% ethanol, and stained with 1% crystal violet for 5 min. The wells were then washed three times with distilled water, air-dried, and the optical density (OD) of each well was measured at 570 nm using an ELISA plate reader. OD of less than 0.1 was considered negative, OD values in the range of 0.126 and 0.9 were considered weakly positive, and OD ≥ 1 was considered strongly positive [45].
The CRA method was used to estimate the slime production according to the change in the color of grown bacteria on CRA. BHI agar supplemented with sucrose (36 g L−1) and Congo red (0.8 g L−1) was prepared for inoculation of S. epidermidis strains, and then incubated overnight at 37 °C. Deep black colonies with a metallic sheen were considered positive, dark pink colonies were considered moderate slime producers, and light pink colonies were considered negative [45].

4.4. Whole-Genome Sequencing (WGS) and Data Analysis

Bacterial genomic DNA was extracted from overnight growth via the quinidine chloride protocol [46], and then the quality of extracted DNA was estimated using NanoDrop and Qubit (Thermo Scientific, Waltham, MA, USA). Paired-end reads (2 × 150 bp) were generated from WGS using Illumina HiSeq 2500 (Novogene, Beijing, China). Before the genomic data analysis, the reads with low-quality, adaptors and reads less than 200 bp were removed using Trimmomatic 0.36 [47]. The PATRIC server was used for de novo genome assembly, and then the assembled reads were submitted to the MLST 2.0 and PubMLST [48] databases for species identification. Subspecies identification and curation of novel strains was achieved with the help of the Institut Pasteur team for the curation and maintenance of the BIGSdb-Pasteur databases. Genome annotation was achieved with the PATRIC server and NCBI Prokaryotic Genome Annotation Pipeline (PGAP) [49].

4.5. Prediction of Resistome and Mobilome

Resistance Gene Identifier (RGI) and ResFinder [50] were used for the prediction of antimicrobial resistance genes (ARGs). Genes were identified based on a >80% hit length and >90% sequence identity. SCCmecFinder v.1.2 [51] was used for the identification of mecA-carrying SCCmec; the default parameters were applied with minimum thresholds of sequence identity (>90%) and sequence coverage (>60%). Plasmids were screened using the plasmidSPAdes tool v3.15.4 [52] and PlasmidFinder 2.1 (Center for Genomic Epidemiology, DTU, Lyngby, Denmark). SnapGene Viewer v.6.0.2 was used for the visualization of gene cassettes. Virulence genes were investigated using the virulence factor database (VFDB) [53], using S. epidermidis RP62A as a reference strain for comparison [54].

4.6. Pan-Genome Analysis and Phylogenetic Tree

The rapid annotation of prokaryotic genomes (Prokka) [55] tool was used for annotation of the assembled contigs of our isolates and reference strains of S. epidermidis (949_S8, BPH0662, RP62A, and ATCC_12228). Roary [56], the pan-genome pipeline, was used for quick generation of a core gene alignment from the gff3 files generated from Prokka, adjusted with identity for BLASTp (95%) and 99% for isolates’ genes to be considered a core. The Gene Presence tool of the BIGSdb-Pasteur databases was used to compare whole-genome data of the isolates with the database-defined loci of an annotated genome used for comparison.
Maximum-likelihood-based inference of large phylogenetic trees (Galaxy Version 8.2.4 + galaxy2) was generated by the phylogenetic reconstruction tool RAxML, and the alignment of the core genes generated by Roary was used as the input, while GTRGAMMA was used as a substitution model.
Another phylogenetic tree was generated against all genomes (57) of S. epidermidis submitted from Africa in the PubMLST database. The Interactive Tree of Life (iTOL) v5 was used for the visualization of the tree.

5. Limitations

Our work had some limitations that should be mentioned. MICs were determined for a limited number of antibiotics due to the unavailability of others in our region, and we faced some difficulties in importing them from abroad.

6. Conclusions

This study focused on the genomic characteristics of methicillin-resistant S. epidermidis, in which we detected novel MDR strains circulating in our hospital setting; these isolates were methicillin-resistant, and carried different types of staphylococcal cassette chromosome (SCC) elements and insertion sequences (ISs) associated with integration and precise excision of the mec-gene complex. Isolate 9SE was identified as having the chlorhexidine resistance (qacA) gene; chlorhexidine is the most commonly used antiseptic, which represents a serious public health problem. Additionally, the 9SE strain possessed different genes associated with biofilm formation (icaA, icaB, icaC, and icaD), which could increase the risk of device-associated hospital-acquired infections. The 9SE strain was identified with extra ccrB4, which was unique to this study; this new composite element of the ccr type needs more focus to better understand its role in the drug resistance mechanism.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics11070861/s1, Supplementary File S1, Figure S1: Congo red agar; Supplementary File S1, Figure S2: S. epidermidis variable genome; Supplementary File S1, Figure S3: Linear representation of S. epidermidis (9SE) phage proteins, Staphylococcal nuclease family protein, mobile element proteins, transposases, and MecA adaptor protein; Supplementary File S1, Figure S4: Circular representation of clustered ARGs in isolate 9SE, the repA gene; Supplementary File S1, Figure S5: Circular representation of S. epidermidis (30SP) plasmid pSER10C-2; Supplementary File S1, Table S1: Genomic characteristics of isolated organisms; Supplementary File S1, Table S2: The virulence factors identified in the isolates; Supplementary File S2 contained the metadata for isolates used in the phylogenetic tree.

Author Contributions

H.N.A.: conceptualization, supervision, bioinformatics analysis, writing—review and editing, funding acquisition. H.S.E.: data acquisition, carried out the microbiological analysis, writing—review and editing. O.B. and I.K.: methodology, software, data curation, formal analysis, writing—review and editing. F.A.A.: methodology, software, data curation, writing—review and editing. M.S.N.: methodology, analysis, writing—review and editing. S.H.: investigations, resources, writing—review and editing. K.C.: validation, supervision, visualization, writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

The authors extend their appreciation to the Deputyship for Research and Innovation, Ministry of Education, Saudi Arabia, for funding this research work through the project number IFPRC-072-130-2020, along with King Abdulaziz University DSR, Jeddah, Saudi Arabia.

Institutional Review Board Statement

This study was approved by the Ethics Committee of the Ministry of Health (REF: 2/2021).

Informed Consent Statement

Not applicable because we collected sample remnants without patients’ identifiable information.

Data Availability Statement

The data of this project were submitted to GenBank under the Bioproject PRJNA767482, Accession numbers JAKKEA000000000 (9SE), JAKKED000000000 (14SP), and JAKKEK000000000 (30SP), and under the following biosamples: SAMN25227152 (9SE), SAMN25227155 (14SP), and SAMN25227162 (30SP). Additional tables and figures are listed in the Supplementary Materials.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Guo, H.; Tong, Y.; Cheng, J.; Abbas, Z.; Li, Z.; Wang, J.; Zhou, Y.; Si, D.; Zhang, R. Biofilm and Small Colony Variants An Update on Staphylococcus aureus Strategies toward Drug Resistance. Int. J. Mol. Sci. 2022, 23, 1241. [Google Scholar] [CrossRef] [PubMed]
  2. Joubert, I.A.; Otto, M.; Strunk, T.; Currie, A.J. Look Who’s Talking: Host and Pathogen Drivers of Staphylococcus epidermidis Virulence in Neonatal Sepsis. Int. J. Mol. Sci. 2022, 23, 860. [Google Scholar] [CrossRef] [PubMed]
  3. Salgueiro, V.C.; Iorio, N.L.P.; Ferreira, M.C.; Chamon, R.C.; Dos Santos, K.R.N. Methicillin resistance and virulence genes in invasive and nasal Staphylococcus epidermidis isolates from neonates. BMC Microbiol. 2017, 17, 15. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Bui, L.M.; Conlon, B.P.; Kidd, S.P. Antibiotic tolerance and the alternative lifestyles of Staphylococcus aureus. Essays Biochem. 2017, 61, 71–79. [Google Scholar]
  5. Holden, M.T.; Feil, E.J.; Lindsay, J.A.; Peacock, S.J.; Day, N.P.; Enright, M.C.; Foster, T.J.; Moore, C.E.; Hurst, L.; Atkin, R. Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. USA 2004, 101, 9786–9791. [Google Scholar] [CrossRef] [Green Version]
  6. Razavi, S.; Dadashi, M.; Pormohammad, A.; Khoramrooz, S.S.; Mirzaii, M.; Gholipour, A.; Darban-Sarokhalil, D. Methicillin-resistant staphylococcus epidermidis in Iran: A systematic review and meta-analysis. Arch. Clin. Infect. Dis. 2018, 13, e58410. [Google Scholar] [CrossRef] [Green Version]
  7. Oliver, L.V.; Calduch, P.B.; Rodríguez, L.F.; Ortega, D.N.; Samper, A.M.D.; Rodríguez, J.C. Methicillin-resistant Staphylococcus epidermidis infectious keratitis: Clinical and microbiological profile. Rev. Española Quimioter. 2022, 35, 171–177. [Google Scholar] [CrossRef]
  8. Parlet, C.P.; Brown, M.M.; Horswill, A.R. Commensal staphylococci influence Staphylococcus aureus skin colonization and disease. Trends Microbiol. 2019, 27, 497–507. [Google Scholar] [CrossRef]
  9. Kalantar-Neyestanaki, D.; Mansouri, S.; Tadjrobehkar, O.; Pardakhty, A.; Tabatabaeifar, F.; Morones-Ramírez, J.R.; Jamali, Z.; Isaei, E. High prevalence of multi-drug resistant and different SCCmec types among coagulase-negative Staphylococci spp. collected from clinical samples and skin of healthcare workers in Kerman, Southeast Iran. Gene Rep. 2022, 26, 101428. [Google Scholar] [CrossRef]
  10. Bekoe, S.O.; Hane-Weijman, S.; Trads, S.L.; Orman, E.; Opintan, J.; Hansen, M.; Frimodt-Møller, N.; Styrishave, B. Reservoir of Antibiotic Residues and Resistant Coagulase Negative Staphylococci in a Healthy Population in the Greater Accra Region, Ghana. Antibiotics 2022, 11, 119. [Google Scholar] [CrossRef]
  11. Michels, R.; Last, K.; Becker, S.L.; Papan, C. Update on coagulase-negative Staphylococci—What the clinician should know. Microorganisms 2021, 9, 830. [Google Scholar] [CrossRef] [PubMed]
  12. Michalik, M.; Samet, A.; Podbielska-Kubera, A.; Savini, V.; Międzobrodzki, J.; Kosecka-Strojek, M. Coagulase-negative staphylococci (CoNS) as a significant etiological factor of laryngological infections: A review. Ann. Clin. Microbiol. Antimicrob. 2020, 19, 26. [Google Scholar] [CrossRef] [PubMed]
  13. Heilmann, C.; Ziebuhr, W.; Becker, K. Are coagulase-negative staphylococci virulent? Clin. Microbiol. Infect. 2019, 25, 1071–1080. [Google Scholar] [CrossRef] [PubMed]
  14. Pinheiro-Hubinger, L.; Moraes Riboli, D.F.; Abraão, L.M.; Pereira Franchi, E.P.L.; da Cunha, R.D.S.; de Lourdes, M. Coagulase-Negative Staphylococci Clones Are Widely Distributed in the Hospital and Community. Pathogens 2021, 10, 792. [Google Scholar] [CrossRef]
  15. Liu, J.; Chen, D.; Peters, B.M.; Li, L.; Li, B.; Xu, Z.; Shirliff, M.E. Staphylococcal chromosomal cassettes mec (SCCmec): A mobile genetic element in methicillin-resistant Staphylococcus aureus. Microb. Pathog. 2016, 101, 56–67. [Google Scholar] [CrossRef]
  16. Uehara, Y. Current Status of Staphylococcal Cassette Chromosome mec (SCCmec). Antibiotics 2022, 11, 86. [Google Scholar] [CrossRef]
  17. Svensson, K.; Hellmark, B.; Söderquist, B. Characterization of SCCmec elements in methicillin-resistant Staphylococcus epidermidis isolated from blood cultures from neonates during three decades. Apmis 2011, 119, 885–893. [Google Scholar] [CrossRef]
  18. Chikkaraddi, U.; Nandihal, N.W. Clinico-bacteriological profile and antibiogram of Staphylococcus epidermidis with special emphasis on Methicillin resistance and hospital acquired infections in a tertiary care center south India. Indian J. Microbiol. Res. 2022, 9, 34–40. [Google Scholar]
  19. Wayne, P. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Thirtieth Informational Supplement. Inform. Suppl. 2020, 31, 100–121. [Google Scholar]
  20. Zhou, S.; Chao, X.; Fei, M.; Dai, Y.; Liu, B. Analysis of S. Epidermidis icaA and icaD genes by polymerase chain reaction and slime production: A case control study. BMC Infect. Dis. 2013, 13, 242–247. [Google Scholar] [CrossRef] [Green Version]
  21. Ibrahem, S.; Salmenlinna, S.; Lyytikäinen, O.; Vaara, M.; Vuopio-Varkila, J. Molecular characterization of methicillin-resistant Staphylococcus epidermidis strains from bacteraemic patients. Clin. Microbiol. Infect. 2008, 14, 1020–1027. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Argemi, X.; Hansmann, Y.; Prola, K.; Prévost, G. Coagulase-negative staphylococci pathogenomics. Int. J. Mol. Sci. 2019, 20, 1215. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Otto, M. Molecular basis of Staphylococcus epidermidis infections. In Seminars in Immunopathology; Springer: Berlin/Heidelberg, Germany, 2012; pp. 201–214. [Google Scholar]
  24. Lee, J.Y.; Monk, I.R.; Gonçalves da Silva, A.; Seemann, T.; Chua, K.Y.; Kearns, A.; Hill, R.; Woodford, N.; Bartels, M.D.; Strommenger, B. Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis. Nat. Microbiol. 2018, 3, 1175–1185. [Google Scholar] [CrossRef]
  25. Chen, S.; Rao, L.; Lin, C. The Dissemination of Fusidic Acid Resistance Among Staphylococcus epidermidis Clinical Isolates in Wenzhou, China. Infect. Drug Resist. 2022, 15, 2537. [Google Scholar] [CrossRef]
  26. Sharma, P.; Satorius, A.E.; Raff, M.R.; Rivera, A.; Newton, D.W.; Younger, J.G. Multilocus sequence typing for interpreting blood isolates of Staphylococcus epidermidis. Interdiscip. Perspect. Infect. Dis. 2014, 2014, 787458. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Mertens, A.; Ghebremedhin, B. Genetic determinants and biofilm formation of clinical Staphylococcus epidermidis isolates from blood cultures and indwelling devises. Eur. J. Microbiol. Immunol. 2013, 3, 111–119. [Google Scholar] [CrossRef] [Green Version]
  28. Månsson, E.; Johannesen, T.B.; Nilsdotter-Augustinsson, Å.; Söderquist, B.; Stegger, M. Comparative genomics of Staphylococcus epidermidis from prosthetic-joint infections and nares highlights genetic traits associated with antimicrobial resistance, not virulence. Microb. Genom. 2021, 7, 000504. [Google Scholar] [CrossRef]
  29. Do Vale, B.C.M.; Nogueira, A.G.; Cidral, T.A.; Lopes, M.C.S.; de Melo, M.C.N. Decreased susceptibility to chlorhexidine and distribution of qacA/B genes among coagulase-negative Staphylococcus clinical samples. BMC Infect. Dis. 2019, 19, 199. [Google Scholar] [CrossRef]
  30. Yılmaz, E.Ş.; Aslantaş, Ö. Antimicrobial resistance and underlying mechanisms in Staphylococcus aureus isolates. Asian Pac. J. Trop. Med. 2017, 10, 1059–1064. [Google Scholar] [CrossRef]
  31. Elbadawi, H.S.; Elhag, K.; Mahgoub, E.; Altayb, H.N.; Hamid, M.M.A. Prevalence and Molecular Characterization of Carbapenem Resistance Gram Negative Bacilli among Hospitalized Patients in Khartoum State. 2019. Available online: https://www.researchsquare.com/article/rs-4748/latest.pdf (accessed on 20 June 2022).
  32. Kwong, S.M.; Ramsay, J.P.; Jensen, S.O.; Firth, N. Replication of staphylococcal resistance plasmids. Front. Microbiol. 2017, 8, 2279. [Google Scholar] [CrossRef] [Green Version]
  33. Schumacher, M.A.; Tonthat, N.K.; Kwong, S.M.; babu Chinnam, N.; Liu, M.A.; Skurray, R.A.; Firth, N. Mechanism of staphylococcal multiresistance plasmid replication origin assembly by the RepA protein. Proc. Natl. Acad. Sci. USA 2014, 111, 9121–9126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Udo, E.E.; Boswihi, S.S.; Mathew, B.; Noronha, B.; Verghese, T. Resurgence of chloramphenicol resistance in methicillin-resistant staphylococcus aureus due to the acquisition of a variant florfenicol exporter (Fexav)-mediated chloramphenicol resistance in Kuwait hospitals. Antibiotics 2021, 10, 1250. [Google Scholar] [CrossRef] [PubMed]
  35. Khaledi, A.; Esmaeili, D.; Jamehdar, S.A.; Esmaeili, S.-A.; Neshani, A.; Bahador, A. Expression of MFS efflux pumps among multidrug resistant Acinetobacter baumannii clinical isolates. Der Pharm. Lett. 2016, 8, 262–267. [Google Scholar]
  36. Conlan, S.; Mijares, L.A.; Becker, J.; Blakesley, R.W.; Bouffard, G.G.; Brooks, S.; Coleman, H.; Gupta, J.; Gurson, N.; Park, M. Staphylococcus epidermidis pan-genome sequence analysis reveals diversity of skin commensal and hospital infection-associated isolates. Genome Biol. 2012, 13, R64. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Chu, M.; Zhou, M.; Jiang, C.; Chen, X.; Guo, L.; Zhang, M.; Chu, Z.; Wang, Y. Staphylococcus aureus phenol-soluble modulins α1–α3 act as novel toll-like receptor (TLR) 4 antagonists to inhibit HMGB1/TLR4/NF-κB signaling pathway. Front. Immunol. 2018, 9, 862. [Google Scholar] [CrossRef] [Green Version]
  38. Asante, J.; Hetsa, B.A.; Amoako, D.G.; Abia, A.L.K.; Bester, L.A.; Essack, S.Y. Genomic Analysis of Antibiotic-Resistant Staphylococcus epidermidis Isolates From Clinical Sources in the Kwazulu-Natal Province, South Africa. Front. Microbiol. 2021, 12, 656306. [Google Scholar] [CrossRef]
  39. Becker, K.; Both, A.; Weißelberg, S.; Heilmann, C.; Rohde, H. Emergence of coagulase-negative staphylococci. Expert Rev. Anti-Infect. Ther. 2020, 18, 349–366. [Google Scholar] [CrossRef]
  40. Kord, M.; Ardebili, A.; Jamalan, M.; Jahanbakhsh, R.; Behnampour, N.; Ghaemi, E.A. Evaluation of biofilm formation and presence of ica genes in Staphylococcus epidermidis clinical isolates. Osong Public Health Res. Perspect. 2018, 9, 160. [Google Scholar] [CrossRef]
  41. Wauters, G.; Vaneechoutte, M. Approaches to the identification of aerobic Gram-negative bacteria. In Manual of Clinical Microbiology, 11th ed.; Jorgensen, J.H., Pfaller, M.A., Carroll, K.C., Funke, G., Landry, M.L., Richter, S.S., Warnock, D.W., Eds.; ASM Press: Washington, DC, USA, 2015; pp. 613–634. [Google Scholar]
  42. Mogana, R.; Adhikari, A.; Tzar, M.; Ramliza, R.; Wiart, C. Antibacterial activities of the extracts, fractions and isolated compounds from Canarium patentinervium Miq. against bacterial clinical isolates. BMC Complementary Med. Ther. 2020, 20, 55. [Google Scholar] [CrossRef] [Green Version]
  43. Kouidhi, B.; Zmantar, T.; Jrah, H.; Souiden, Y.; Chaieb, K.; Mahdouani, K.; Bakhrouf, A. Antibacterial and resistance-modifying activities of thymoquinone against oral pathogens. Ann. Clin. Microbiol. Antimicrob. 2011, 10, 29. [Google Scholar] [CrossRef] [Green Version]
  44. Chaieb, K.; Chehab, O.; Zmantar, T.; Rouabhia, M.; Mahdouani, K.; Bakhrouf, A. In vitro effect of pH and ethanol on biofilm formation by clinicalica-positiveStaphylococcus epidermidis strains. Ann. Microbiol. 2007, 57, 431–437. [Google Scholar] [CrossRef]
  45. Los, R.; Sawicki, R.; Juda, M.; Stankevic, M.; Rybojad, P.; Sawicki, M.; Malm, A.; Ginalska, G. A comparative analysis of phenotypic and genotypic methods for the determination of the biofilm-forming abilities of Staphylococcus epidermidis. FEMS Microbiol. Lett. 2010, 310, 97–103. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Sabeel, S.; Salih, M.A.; Ali, M.; El-Zaki, S.-E.; Abuzeid, N.; Elgadi, Z.A.M.; Altayb, H.N.; Elegail, A.; Ibrahim, N.Y.; Elamin, B.K. Phenotypic and genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Sudanese patients. Tuberc. Res. Treat. 2017, 2017, 8340746. [Google Scholar]
  47. Bolger, A.M.; Lohse, M.; Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 2014, 30, 2114–2120. [Google Scholar] [CrossRef] [Green Version]
  48. Jolley, K.A.; Bray, J.E.; Maiden, M.C. Open-access bacterial population genomics: BIGSdb software, the PubMLST. org website and their applications. Wellcome Open Res. 2018, 3, 124. [Google Scholar] [CrossRef] [PubMed]
  49. Tatusova, T.; DiCuccio, M.; Badretdin, A.; Chetvernin, V.; Nawrocki, E.P.; Zaslavsky, L.; Lomsadze, A.; Pruitt, K.D.; Borodovsky, M.; Ostell, J. NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res. 2016, 44, 6614–6624. [Google Scholar] [CrossRef]
  50. Zankari, E.; Hasman, H.; Cosentino, S.; Vestergaard, M.; Rasmussen, S.; Lund, O.; Aarestrup, F.M.; Larsen, M.V. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 2012, 67, 2640–2644. [Google Scholar] [CrossRef]
  51. Kaya, H.; Hasman, H.; Larsen, J.; Stegger, M.; Johannesen, T.B.; Allesøe, R.L.; Lemvigh, C.K.; Aarestrup, F.M.; Lund, O.; Larsen, A.R. SCC mec Finder, a web-based tool for typing of staphylococcal cassette chromosome mec in Staphylococcus aureus using whole-genome sequence data. Msphere 2018, 3, e00612–e00617. [Google Scholar] [CrossRef] [Green Version]
  52. Antipov, D.; Hartwick, N.; Shen, M.; Raiko, M.; Lapidus, A.; Pevzner, P.A. plasmidSPAdes: Assembling plasmids from whole genome sequencing data. Bioinformatics 2016, 32, 3380–3387. [Google Scholar] [CrossRef] [Green Version]
  53. Liu, B.; Zheng, D.; Jin, Q.; Chen, L.; Yang, J. VFDB 2019: A comparative pathogenomic platform with an interactive web interface. Nucleic Acids Res. 2019, 47, D687–D692. [Google Scholar] [CrossRef]
  54. Raue, S.; Fan, S.-H.; Rosenstein, R.; Zabel, S.; Luqman, A.; Nieselt, K.; Götz, F. The genome of Staphylococcus epidermidis O47. Front. Microbiol. 2020, 11, 2061. [Google Scholar] [CrossRef] [PubMed]
  55. Seemann, T. Prokka: Rapid prokaryotic genome annotation. Bioinformatics 2014, 30, 2068–2069. [Google Scholar] [CrossRef] [PubMed]
  56. Page, A.J.; Cummins, C.A.; Hunt, M.; Wong, V.K.; Reuter, S.; Holden, M.T.; Fookes, M.; Falush, D.; Keane, J.A.; Parkhill, J. Roary: Rapid large-scale prokaryote pan genome analysis. Bioinformatics 2015, 31, 3691–3693. [Google Scholar] [CrossRef] [PubMed]
Antibiotics 11 00861 g001 550
Figure 1. (A–C) Schematic representation of the SCCmec complex (green) in S. epidermidis isolates. The SCCmec is composed of the methicillin resistance gene (mecA), the mecA regulators (mecI and mecR1), and genes associated with integration and excision (ccr gene complex and IS) of the mec-gene complex.
Figure 1. (A–C) Schematic representation of the SCCmec complex (green) in S. epidermidis isolates. The SCCmec is composed of the methicillin resistance gene (mecA), the mecA regulators (mecI and mecR1), and genes associated with integration and excision (ccr gene complex and IS) of the mec-gene complex.
Antibiotics 11 00861 g001
Antibiotics 11 00861 g002 550
Figure 2. Schematic representation of the unique SCC in the 9SE strain, which contains ccrC2 and IS257, shown in green. The purple arrows showing other genes present in the same contig.
Figure 2. Schematic representation of the unique SCC in the 9SE strain, which contains ccrC2 and IS257, shown in green. The purple arrows showing other genes present in the same contig.
Antibiotics 11 00861 g002
Antibiotics 11 00861 g003 550
Figure 3. Circular representation of the maximum likelihood phylogenetic tree of S. epidermidis, including 9SE, 14SP, and 30SP in red, and the most related strain (57) of S. epidermidis submitted from Africa in the PubMLST database. Different clades shown in different colors.
Figure 3. Circular representation of the maximum likelihood phylogenetic tree of S. epidermidis, including 9SE, 14SP, and 30SP in red, and the most related strain (57) of S. epidermidis submitted from Africa in the PubMLST database. Different clades shown in different colors.
Antibiotics 11 00861 g003
Table
Table 1. Antimicrobial susceptibility testing of selected antimicrobial agents used against bacterial isolates.
Table 1. Antimicrobial susceptibility testing of selected antimicrobial agents used against bacterial isolates.
AntibioticStaphylococcus epidermidis
9SE14SP30SP
MIC (μg/mL)Disk Diffusion Susceptibility a MIC (μg/mL)Disk Diffusion Susceptibility a MIC (μg/mL)Disk Diffusion Susceptibility a
Ciprofloxacin≤2S256R256R
Tetracycline32R≤2S32R
Cefoxitin-R-R-R
Erythromycin -S-R-S
Clindamycin-R-S-S
Trimethoprim–sulfamethoxazole-S-R-R
Gentamicin≤2S≤2S≥1024R
Chloramphenicol512R256R512R
Ampicillin 256R≥1024R4R
Abbreviations: R = resistant, S = susceptible, - = not tested, mm = millimeter. a Antimicrobial susceptibility testing determined according to CLSI guidelines [19].
Table
Table 2. Summary of orthologous clusters and single-copy gene clusters of isolated reference strains of S. epidermidis.
Table 2. Summary of orthologous clusters and single-copy gene clusters of isolated reference strains of S. epidermidis.
StrainsProteinsClustersSingletons
S. epidermidis 9SE2285218496
S. epidermidis 14SP2321221299
S. epidermidis 30SP2230215073
S. epidermidis 949_S82119209423
S. epidermidis BPH066226542412182
S. epidermidis RP62A2401230460
S. epidermidis ATCC_1222810,25225832766
Table
Table 3. Presence of genes among S. epidermidis isolates (9SE, 14SP, and 30SP) and reference strains (ATCC12228, RP62A949_S8, and BPH0662) used for comparison.
Table 3. Presence of genes among S. epidermidis isolates (9SE, 14SP, and 30SP) and reference strains (ATCC12228, RP62A949_S8, and BPH0662) used for comparison.
S. epidermidis IDAcetyltransferase CcrA CcrB Fdh IcaAIcaB IcaC IcaD IcaR IS256-like mecAmecCPSM-b1 PSM-mecQacA Tn554
ATCC122280110000000001000
RP62A1110111111111101
949_S80000000000001000
BPH06621110111111111101
9SE1110111111111110
14SP1111000001110000
30SP0011000000110000
1 = Gene present, 0 = gene absent.
Table
Table 4. SCCmec complex types and their positions in S. epidermidis.
Table 4. SCCmec complex types and their positions in S. epidermidis.
IDSCCmec GenesType/Temp Coverage Contig Identity Position in Contig
9SEccrC2-allele-1:1:KR187111III(3A)/63.85%
XIII(9A)		2096.4411,178..12,863
ccrB3:1:852082:AB03767121100.0014,339..15,967
ccrA3:1:852082:AB03767121100.0015,988..17,334
mecA:12:AB50562821100.002522..4531
mecR1:1:D8693421100.004638..6395
mecI:1:D8693421100.006395..6766
14SPmecA:12:AB505628IV(2B&5)/74.73%25100.002560..4569
dmecR1:1:AB03376325100.004666..5652
IS1272:3:AM29230425100.005641..7483
ccrB4:2:BK20781:FJ6705421592.207117..8745
ccrC1-allele-7:1:EF19046811100.0074,999..76,675
subtype-IVc(2B):3:81108:AB09621711100.0085,144..86,298
ccrA2:7:81108:AB09621711100.0090,315..91,664
ccrB2:7:81108:AB09621725100.009325..10,914
30SPmecA:12:AB505628VI(4B)/87.47%3100.00150,689..152,698
dmecR1:1:AB0337633100.00152,795..153,781
IS1272:3:AM2923043100.00153,770..155,612
ccrB4:2:BK20781:FJ670542394.05157,433..159,061
ccrA4:1:HDE288:AF411935399.85159,058..160,419
IS1272:2:AB033763191.12213,133..214,709
Note: IS257 is also known as IS431.
Table
Table 5. Antimicrobial resistance genes present in S. epidermidis isolates.
Table 5. Antimicrobial resistance genes present in S. epidermidis isolates.
S. epidermidisContigARGsPositionCoverageIdentity
9SE5fosB78015-78443100%99.5%
35fusB1634-993100%100%
21mecA2522-4528100%100%
36aac(6′)-aph(2″)1519-80100%99.9%
22fosD78015-78443100%99.5%
qacA12368-13912100%100%
31mupA158-3232100%99.96%
14SP28aadD191-952100%100%
11msr(A)1716-250100%99.7 %
7fosB71675-72103100%96.5%
blaZ130038-130883100%100%
6dfrG58760-59257100%100%
18fusB45606-46247100%100%
25mecA2560-4566100%100%
34aac(6′)-aph(2″)1839-400100%100%
30SP2fosB225233-225661100%96.27%
15msr(A)13445-14911100%99.72%
blaZ8566-9411100%99.88%
3mecA150689-152695100%100%
fusC167439-168077100%99.21%
18tet(K)1122-2501100%100%
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Altayb, H.N.; Elbadawi, H.S.; Baothman, O.; Kazmi, I.; Alzahrani, F.A.; Nadeem, M.S.; Hosawi, S.; Chaieb, K. Whole-Genome Sequence of Multidrug-Resistant Methicillin-Resistant Staphylococcus epidermidis Carrying Biofilm-Associated Genes and a Unique Composite of SCCmec. Antibiotics 2022, 11, 861. https://doi.org/10.3390/antibiotics11070861

AMA Style

Altayb HN, Elbadawi HS, Baothman O, Kazmi I, Alzahrani FA, Nadeem MS, Hosawi S, Chaieb K. Whole-Genome Sequence of Multidrug-Resistant Methicillin-Resistant Staphylococcus epidermidis Carrying Biofilm-Associated Genes and a Unique Composite of SCCmec. Antibiotics. 2022; 11(7):861. https://doi.org/10.3390/antibiotics11070861

Chicago/Turabian Style

Altayb, Hisham N., Hana S. Elbadawi, Othman Baothman, Imran Kazmi, Faisal A. Alzahrani, Muhammad Shahid Nadeem, Salman Hosawi, and Kamel Chaieb. 2022. "Whole-Genome Sequence of Multidrug-Resistant Methicillin-Resistant Staphylococcus epidermidis Carrying Biofilm-Associated Genes and a Unique Composite of SCCmec" Antibiotics 11, no. 7: 861. https://doi.org/10.3390/antibiotics11070861

APA Style

Altayb, H. N., Elbadawi, H. S., Baothman, O., Kazmi, I., Alzahrani, F. A., Nadeem, M. S., Hosawi, S., & Chaieb, K. (2022). Whole-Genome Sequence of Multidrug-Resistant Methicillin-Resistant Staphylococcus epidermidis Carrying Biofilm-Associated Genes and a Unique Composite of SCCmec. Antibiotics, 11(7), 861. https://doi.org/10.3390/antibiotics11070861

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop